David C Wang, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 6829 Elm St, Suite 300, Mc Lean, VA 22101 Phone: 703-532-4892 Fax: 703-237-3105 |
Jennifer Coulter, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8008 Westpark Dr, Mc Lean, VA 22102 Phone: 703-287-6400 |
Dr. Danielle Sunshine Cherrick, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1760 Old Meadow Rd, Ste 500, Mc Lean, VA 22102 Phone: 703-810-5217 Fax: 703-810-5423 |
Christina Victor, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1420 Spring Hill Rd, Mc Lean, VA 22102 Phone: 571-765-1730 |
Mayo F Friedlis, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1750 Tysons Blvd Ste 120, Mc Lean, VA 22102 Phone: 703-914-8000 Fax: 703-642-1876 |
Marc Philip Gruner, D.O. Physical Medicine & Rehabilitation - Sports Medicine Medicare: May Accept Medicare Assignments Practice Location: 8401 Greensboro Dr Ste 120, Mc Lean, VA 22102 Phone: 571-899-3590 Fax: 571-378-1302 |
Dr. Spencer T Tseng, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8008 Westpark Dr, Mc Lean, VA 22102 Phone: 703-287-4675 Fax: 703-922-1111 |
News Archive
Today Boehringer Ingelheim formally acquired Amgen's biopharmaceutical development and manufacturing facility in Fremont, California. This acquisition involves leasing buildings, acquiring physical equipment and assuming manufacturing processes done at the Fremont site.
Viruses are masters of deception, duping their host's cells into helping them grow and spread. A new study has found that human cytomegalovirus (HCMV) can mimic a common regulatory protein to hijack normal cell growth machinery, disrupting a cell's primary anti-cancer mechanism.
On Feb. 22, the day after America watched some of its strongest hearts compete in Vancouver on the 30th anniversary of the "Miracle on Ice" hockey game, a lucky patient at El Camino Hospital was recuperating from his own miracle.
Abbott announced its schedule of key workshops and scientific presentations at the American Association for Clinical Chemistry (AACC) annual meeting, July 24-28 in Atlanta.
In a new Phase III study, BRINAVESSTM (vernakalant) intravenous, an investigational compound being developed in the European Union by Merck (known as MSD outside the USA and Canada) and Cardiome Pharma Corp. to treat atrial fibrillation, showed that BRINAVESS was superior to amiodarone injection, in converting patients' heart rate from atrial fibrillation (AF) to sinus rhythm (SR) within 90 minutes of the start of administration.
› Verified 9 days ago